Quest Diagnostics (DGX) Deferred Taxes: 2009-2025
Historic Deferred Taxes for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $110.0 million.
- Quest Diagnostics' Deferred Taxes rose 633.33% to $110.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.0 million, marking a year-over-year increase of 590.32%. This contributed to the annual value of $13.0 million for FY2024, which is 126.53% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' Deferred Taxes is $110.0 million, which was up 10,900.00% from $1.0 million recorded in Q2 2025.
- Quest Diagnostics' Deferred Taxes' 5-year high stood at $110.0 million during Q3 2025, with a 5-year trough of -$72.0 million in Q2 2021.
- For the 3-year period, Quest Diagnostics' Deferred Taxes averaged around $7.5 million, with its median value being -$4.0 million (2023).
- Its Deferred Taxes has fluctuated over the past 5 years, first tumbled by 900.00% in 2021, then spiked by 3,150.00% in 2022.
- Quarterly analysis of 5 years shows Quest Diagnostics' Deferred Taxes stood at $30.0 million in 2021, then plummeted by 246.67% to -$44.0 million in 2022, then soared by 77.27% to -$10.0 million in 2023, then spiked by 440.00% to $34.0 million in 2024, then skyrocketed by 633.33% to $110.0 million in 2025.
- Its Deferred Taxes stands at $110.0 million for Q3 2025, versus $1.0 million for Q2 2025 and $7.0 million for Q1 2025.